New Digital Therapies Developed For Schizophrenia and Multiple Sclerosis Patients
Novartis and Pear Therapeutics have joined forces to develop digital therapeutic software applications to treat patients with schizophrenia and multiple sclerosis, reports World Pharma News. Novartis is known for the…